Argent Trust Co Sells 1,055 Shares of Colgate-Palmolive Company (NYSE:CL)

Argent Trust Co cut its holdings in Colgate-Palmolive Company (NYSE:CL) by 0.7% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 143,074 shares of the company’s stock after selling 1,055 shares during the period. Argent Trust Co’s holdings in Colgate-Palmolive were worth $13,406,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of CL. Westend Capital Management LLC boosted its holdings in Colgate-Palmolive by 111.1% in the 1st quarter. Westend Capital Management LLC now owns 266 shares of the company’s stock worth $25,000 after buying an additional 140 shares during the period. Cornerstone Planning Group LLC boosted its holdings in Colgate-Palmolive by 1,913.3% in the 1st quarter. Cornerstone Planning Group LLC now owns 302 shares of the company’s stock worth $28,000 after buying an additional 287 shares during the period. Vermillion Wealth Management Inc. bought a new position in Colgate-Palmolive in the 4th quarter worth approximately $31,000. Bernard Wealth Management Corp. bought a new position in Colgate-Palmolive in the 4th quarter worth approximately $33,000. Finally, Accredited Wealth Management LLC bought a new position in Colgate-Palmolive in the 4th quarter worth approximately $34,000. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Stock Performance

NYSE CL opened at $83.51 on Friday. Colgate-Palmolive Company has a 52-week low of $82.70 and a 52-week high of $109.30. The company has a debt-to-equity ratio of 8.96, a quick ratio of 0.54 and a current ratio of 0.85. The company has a market capitalization of $67.68 billion, a P/E ratio of 23.46, a P/E/G ratio of 4.31 and a beta of 0.35. The company has a fifty day moving average of $89.59 and a 200-day moving average of $90.30.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.52% and a return on equity of 461.04%. The company had revenue of $5.11 billion during the quarter, compared to the consensus estimate of $5.03 billion. During the same period in the previous year, the firm posted $0.91 EPS. The firm’s revenue was up 1.0% compared to the same quarter last year. As a group, equities research analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 15th. Stockholders of record on Friday, July 18th will be issued a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date of this dividend is Friday, July 18th. Colgate-Palmolive’s payout ratio is currently 58.76%.

Analysts Set New Price Targets

Several research analysts have commented on the stock. Wall Street Zen downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Wednesday, May 7th. Citigroup raised their price target on shares of Colgate-Palmolive from $103.00 to $108.00 and gave the company a “buy” rating in a report on Monday, April 28th. JPMorgan Chase & Co. cut their price target on shares of Colgate-Palmolive from $103.00 to $99.00 and set an “overweight” rating for the company in a report on Friday, July 25th. UBS Group cut their price target on shares of Colgate-Palmolive from $109.00 to $106.00 and set a “buy” rating for the company in a report on Thursday, July 17th. Finally, Barclays raised their price target on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the company an “equal weight” rating in a report on Tuesday, July 15th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat, Colgate-Palmolive presently has an average rating of “Hold” and an average target price of $100.58.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.